Latest news

Liva Healthcare continues its impressive growth trajectory with the appointment of a Chief Commercial Officer (CCO) and 13 contract wins across healthcare providers, insurance and pharmaceutical organisations. This follows an investment of €8 million from three German venture funds in 2019. Jonas Hjortshøj joins the senior leadership team at Liva as Chief Commercial Officer. Jonas brings […]

Bump2Baby and Me is a new project awarded funding from the EU’s Horizon 2020 research and development programme. Led by University College Dublin, this five-year project will address weight management during and after pregnancy. The goal of the ‘Bump2Baby and Me’ project is to deliver implementable solutions for hospitals and health service providers to better […]

Dr Roger Henderson, UK medical director at Liva Healthcare, provides his top tips for those looking to make long-term behaviour and lifestyle health changes in 2020: 1. Set realistic goals The first step towards making long term lifestyle changes is to set goals that are realistic for you. Goals need to be individual, measurable and […]

This month the Liva Healthcare digital health platform has been recognised by ORCHA, a leading health app evaluation organisation, with a top-level four rating. ORCHA With four million health apps being downloaded every day, and 325,000 to choose from, it’s hard for healthcare practitioners and  health bodies to find the best apps. ORCHA is the […]

Dansk Sundhedssikring and Liva Healthcare partner to help thousands of people prevent and manage chronic conditions  Danish health insurance company Dansk Sundhedssikring and Liva Healthcare today announce a new partnership which aims to help more than 100,000 Danish customers prevent and manage chronic conditions such as Type 2 diabetes, pre-diabetes, cardiovascular disease, high blood pressure […]

Kristoffer From, CEO of Liva Healthcare To support our ambitious 2020 growth plans, I am pleased to share we have expanded our team with five executive hires across both the UK and Denmark office. This will allow us to scale up with existing clients, expand further geographically and continue our technological innovation. The UK office In our UK […]

For World Diabetes Day, our UK medical director Dr Roger Henderson, and patient Bill Bachop, were invited onto Sky News to discuss the role of digital health intervention for the treatment of Type 2 diabetes. Living in the dark During the interview, Dr Henderson explained that in the UK around half a million of people […]

It’s been a fantastic year so far for Liva Healthcare. In just nine months we have been shortlisted for seven awards, winning two, with more yet to be announced. Our proven results in halting the progression of, or reversing chronic conditions has been recognised by the Health Investor, Forward Healthcare, Health Technology Newspaper and European […]

Liva Healthcare, the digital health coaching company, announces that it has secured funding from the EU Horizon 2020 fund to develop the: ‘Impact Diabetes Baby 2 Bump’ research project. Working with a highly skilled international team of researchers from seven universities across the globe including the University College Dublin, the University of Bristol and the […]

Liva Healthcare has announced a new partnership with Care City as part of the NHS Test Bed programme funded by NHS England and the Department of Health and Social Care. Focused on tackling the challenges laid out in the NHS Five-Year Forward View the programme brings NHS organisations and industry partners together to test combinations of […]

Liva Healthcare and Living Well Taking Control (LWTC) have today been announced by NHS England as a joint provider in the Healthier You: NHS Diabetes Prevention Programme (NHS DPP). With Liva offering a digital service to complement LWTC’s face-to-face intervention programme in delivering diabetes and obesity prevention for the next five years. Type 2 diabetes is one […]

The European digital health company Liva Healthcare today announced an investment of eight million euro from three German venture funds, MIG (Munich), Santo Venture Capital (Holzkirchen) and Digital Health Ventures (Berlin).